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In recent years, a huge number of scientific studies devoted to the implementa-
tion of the patient's doctor's appointment. Against the background of the discrepancy 
between the possibilities of modern methods of treatment and the real successes, the 
relevance of this problem is obvious. In describing the problem, the terms compliance 
and adherence are used, which are essentially synonyms and reflect the degree of con-
formity the patient's behavior to the doctor's recommendations regarding medication 
administration, diet and other therapeutic measures. Most often, these concepts are 
applied in relation to pharmacotherapy and measure the degree of adherence quantita-
tively, assessing the ratio of the doses of drug taken/prescribed to the patient [1]. 
There is no universally accepted system of evaluation of the Complaence and even the 
semantic content of various authors differs, its importance can hardly be overestimat-
ed. The strong dependence between adherence to therapy and its effectiveness has 
been proved [2]. Inaccurate implementation of medical recommendations leads to the 
progression of the disease, an increase in the duration and cost of treatment, the de-
velopment of complications and side effects. This, in turn, creates a patient's distrust 
of both the doctor and the very idea of successful treatment. A systematic analysis of 
79 studies (total number of clinical cases 230,000) found that low adherence to chron-
ic disease treatment leads to a significant increase in the cost of treatment - an average 
of 83% [3].   It was found that medication non-adherence leads to a 2-fold increase in 
hospital admissions [4]. 
The problem of compliance exists as much as medicine. The Bible also describes 
the story of the Syrian military leader Naaman, who did not want to follow the advice 
of the prophet Eliseus on the treatment of leprosy [5]. Hippocrates quote is known: 
“The doctor must know that patients often lie when they say they have taken medica-
tion.” The statement from former surgeon C. Everett Koop concluded that “Drugs 
don’t work in patients who don’t take them” [6]. The incidence of non-adherence is 
very high, in chronic diseases requiring long-term therapy, it reaches 60%. The inci-
dence of non-complains is very high, in chronic diseases requiring long-term thera-
py; it reaches 60% [7].  It is believed that complete compliance is just the middle 
point on a wide continuum of commitment of patients to the treatment (from total or 
partial resistance to therapy to abuse) [8]. Numerous studies confirm the difficulty of 
achieving high adherence in patients of all age categories. The problem of compli-
ance is polyetiological and multifaceted; it has many aspects. The reasons for the de-
cline in adherence to therapy can be very different and they are far from always asso-
ciated with the patient himself. The influence of various factors on the formation of 
compliance is revealed in their relationship. None of them individually have a deci-
sive effect on compliance [9]. 
 
 
5 
This article aims to highlight the specifics of factors that affect the compliance 
of elderly and senile patients. The geriatric group is predominant not only for a gen-
eral practitioner (therapist, family doctor), but also for doctors of most specialties. 
The demographic situation that defines this state of affairs in recent decades is charac-
teristic not only of Ukraine, which can be safely called the country of pensioners, but 
also of the countries of the European Union. In the United States, the proportion of 
people over 60 years of age is 12%, and they consume about 30% of all drugs issued 
in this country [10, 11]. According to the results of statistical studies, medication non-
adherence is 30% more common in elderly patients than in middle-aged people [12]. 
To achieve the goal, an analysis of scientific publications on the issue of adherence of 
elderly patients to drug therapy was carried out. For the analysis, we used scientific 
papers published in 2016-2020 in journals indexed in the scientometric databases 
Scopus, WebOfScience, MedLine and PubMed.  
Analytical studies of the causes of low adherence to pharmacotherapy in elderly 
patients revealed the influence of several factors: various factors of medication non-
adherence were complexity of medication regimen, lack of knowledge about the dis-
ease and therapy, difficulty in remembering to take medications, taking so many pills 
at the same time, missed dose of treatment [13]. 
The socio-economic factor has a strong influence on the compliance of geriatric 
patients, especially in modern crisis conditions. The cost of drugs prescribed for tak-
ing often exceeds the pensioner's income and makes it even more dependent on able-
bodied relatives. The psychology of any person very much depends on his income 
and determines his assessment of the need for certain goods and services. An Austri-
an writer Marie von Ebner-Eschenbach accurately estimated that "doctors hate either 
from persuasion or from economy."  The average Ukrainian retiree prefers domestic 
drugs to imported ones, because "they are not faked" and not because it is cheaper. 
He refuses to take several medications for a long time, as it is “harmful to the liver” 
and not because the budget does not allow it. He is also sure that doctors and adver-
tising recommend anticoagulant and statins because they “have a percentage of 
sales” and not because they really need to. The combination of several chronic, long-
term current diseases significantly increases the amount needed for constant drug use 
and, accordingly, the cost of treatment [14]. The need for multiple drugs has a nega-
tive effect on patient adherence even at a low cost: There is a well-known inverse re-
lationship between the amount of drugs taken and adherence [15]. It was found that 
with an increase in the number of drugs taken from one to four per day, the probabil-
ity of fulfilling appointments by patients older than 65 decreases by half, in patients 
younger than 65 this dependence is much weaker [16]. In addition, multicomponent 
and complex drug regimens raise concerns about the occurrence of side effects, which 
provides a negative placebo effect [17].   
Polymorbidity (a combination of several long-running chronic diseases) - an-
other important feature of geriatric patients that makes compliance difficult: accord-
ing to statistics, an average of 8 significant chronic diseases is detected in elderly and 
old people at the same time. The polymorbidity of the geriatric patient determines the 
need for observation in several narrow specialists at the same time, which inevitably 
gives rise to polypharmacy [18]. Even if each specialist tries to take into account 
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all the combined pathology (and this, unfortunately, is not often), an elderly patient 
appoints at least 3 or 4 pharmaceutical products [19].  It is easy to imagine that the 
general list will consist of 15-20 drugs and, even if the patient tries to perform all as-
signments at first, the rapid appearance of side effects brings the compliance to zero 
[20].  
Longitudinal cohort study using register data of 711,432 older adults (aged 65 
years and older) living in Sweden with five or more prescription drugs revealed: 
polypharmacy is most often chronic, although a substantial share of older adults expe-
rience short, recurring episodes of polypharmacy and are thus exposed to its potential 
harms in a transient rather than persistent manner [21]. The severity of the side effects 
may be such that Francis Bacon’s phrase is inadvertently recalled that “the cure can 
be worse than the disease.” It is extremely difficult to trace the relationship of these 
side effects by any particular medicines with such a quantity. Side effects are a very 
important factor in reducing adherence to therapy in geriatrics. An age-related de-
crease in the function of detoxification systems, which is progressively progressing 
against the backdrop of chronic diseases, creates the most favorable conditions for 
their manifestation due to relative overdose [22].  
The need to take several groups of pharmaceuticals exacerbates the situation. 
Absolute overdose, as a rule, is caused by forgetfulness due to cognitive impairment 
on the background of discirculatory encephalopathy. Vascular dementia of varying 
severity occurs in most geriatric patients [23]. In patients there is a weakening of 
memory for past and current events, a decrease in the level of judgments, asthenia, a 
slowing of mental processes. Discirculatory disorders reduce hearing and visual acui-
ty.  To reach mutual understanding with a person who sees poorly, does not hear 
well, not understands what he has seen and heard, and, in addition to everything, very 
often in a bad mood, is an extremely difficult task [24]. Age-related disorders of 
pharmacodynamics and pharmacokinetics in the elderly are caused by a decrease in 
the enzymatic activity of the liver and the metabolic rate of pharmaceuticals; a de-
crease in the penetration of medicines into the tissues; decreased functional capabili-
ties of the kidneys; a decrease in the binding of medicines to blood proteins; receptor 
sensitivity changes. Significantly more often, elderly patients develop withdrawal 
symptoms, which is especially noticeable in relation to antihypertensive and psycho-
tropic pharmaceuticals. 
Another important factor to consider is the psychological characteristics of an 
older person. Undoubtedly, the key question of compliance of any patient is the ques-
tion of trust in the attending physician. Many patients, like Voltaire, believe that 
"doctors are those who prescribe medications that they know little about to treat dis-
eases that they know even less about in people about whom they know nothing at all."  
Gaining the trust of an elderly person is much more difficult. From the height of his 
life experience, an elderly patient not only does not take his children and grandchil-
dren, quite solid in terms of position in society, but can treat a doctor condescending-
ly [25]. In addition, old age is a period of a person’s life that is not often perceived 
positively by the person himself. Changing social status, changing lifestyle, narrow-
ing the circle of friends affects the psychological status. In geriatric practice, the atti-
tude of family members to an elderly per- son and his illness is very important. An 
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elderly patient very often depends on the family not only financially, but also physi-
cally. Therefore, the compliance of the patient’s relatives is no less important [26].  A 
large-scale study of Norwegian geriatricians showed that the effectiveness of pharma-
cotherapy increases significantly when elderly people are treated at home with coop-
eration between geriatricians and general practitioners [27]. 
In addition to these factors that determine the compliance of an elderly patient, 
there are many others related to the characteristics of the disease, the health system and 
the attending physician himself. It is he who must take into account all these influences 
in order to achieve maximum patient commitment. A physician is the most influential 
agent in the formation of compliance; his authority and personal qualities acquire spe-
cial significance. Hippocrates instructed to remember that the success of healing is 
largely determined by the patient’s trust in the doctor: “Let him also be a beautiful and 
kind person, and as such significant and philanthropic”. The close and stable relation-
ships that are usually formed in geriatric practice between the doctor and the patient 
help to achieve mutual understanding [28]. The patient and his family are imbued with 
an understanding of the need to perform doctor's prescriptions, and for this it is neces-
sary to provide detailed information in an accessible form. The doctor understands 
and takes into account when prescribing treatment all the features of an elderly patient 
and his family. There are already "technical" methods that have proven themselves in 
practice to solve typical compliance problems [29].  So, in order to exclude 
polypharmacy, the attending physician assumes the role of coordinator of the strategy 
and tactics of patient management and agrees on the appointment of all specialists 
[30].  
William Osler wrote: “A novice doctor prescribes twenty medicines for each dis-
ease; an experienced doctor - one medicine for twenty diseases.” To reduce the num-
ber of prescriptions from the treatment plan, drugs that are duplicated in effect are re-
moved. When choosing pharmaceuticals, preference is given to drugs that provide 
multiple effects [31].  To reduce the multiplicity of intake (and, accordingly, their 
number), prolonged medicines of daily action are selected. The reduction of the total 
number of doses is also achieved by the appointment of combined pharmaceuticals 
[32]. It is known that the patient’s attitude to the medication is affected even by his 
appearance and organoleptic properties. All of these actions can reduce the financial 
costs of therapy, which is extremely important to increase compliance. If necessary, a 
further reduction in the cost of treatment is possible by replacing the original drugs 
with generic ones [33]. To overcome the difficulties caused by cognitive disorders, 
you can use various "forget-me-not's" (from tablets with large font to electronic gadg-
ets). The monitoring participation of both relatives and the doctor himself is always 
relevant. The ability to quickly contact a doctor if necessary and get advice is very 
important. Researchers at the University of Lynchburg have proven the high efficien-
cy of Patient Adherence Programs in Activation [34]. 
Conclusions. Thus, a high adherence to the treatment of elderly patients is possi-
ble due to a set of measures, the main organizational role of which is played by the 
attending physician [35]. The main conditions for ensuring a high medication adher-
ence in elderly patients: the coordinating role of the family doctor; geriatrician adviso-
ry assistance; the most simple pharmacotherapy regimens; the priority of the admin-
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istration of prolonged and multicomponent medicines; control of pharmaceuticals ad-
ministration by family members of an elderly patient; patient training on self-
monitoring methods of taking drugs; monitoring of liver and kidney function accord-
ing to laboratory tests. The application of these principles of pharmacotherapy for el-
derly patients will significantly increase the effectiveness of the treatment. 
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